http://orcid.org/0000-0001-8512-9097
References
- Access to affordable essential medicines. [cited 2012 Mar 27]. Available from: www.who.int/medicines/mdg/MDG08ChapterEMedsEn.pdf
- Drug prices are voters’ top health policy concern. [cited 2016 Oct 27] . Available from: time.com/money/4548002/election-2016-drug-prices/
- Conti R, Rosenthal M. Pharmaceutical policy reform — balancing affordability with incentives for innovation. N Engl J Med. 2016;374(8).
- Cure S, Guerra I. Cost-effectiveness and long-term outcomes of sovaldi (sofosbuvir) for the treatment of chronic Hepatitis C Infected (HCV) patients from a Swedish societal Perspective. Value Health. 2014: 17(7):1.
- Iyengar S, Tay-Teo K, Vogler S et al. Prices, costs, and affordability of new medicines for Hepatitis C in 30 countries: an economic analysis. PLoS Med. 2016;13(5):e1002032.
- AMNOG - evaluation of new pharmaceutical. [cited 2017 May 03]. Available from: https://www.gkv-spitzenverband.de/english/statutory_health_insurance/amnog_evaluation_of_new_pharmaceutical/amnog_english.jsp
- Changes to AMNOG. [cited 2017 Mar 10]. Available from https://mapbiopharma.com/blog/news/news-germany/2017/changes-to-amnog/
- L’évaluation micro-économique des médicaments et dispositifs médicaux. [cited 2014 Dec 18]. Available from: https://www.has-sante.fr/portail/upload/docs/application/pdf/2014-12/dossier_presse_evaluation_medico_eco.pdf
- Budget 2018: un effort sans précédents est demandé à l’assurance-maladie. [cited 2017 Sept 27]. Available from: https://www.lesechos.fr/economie-france/social/030623582045-un-effort-sans-precedent-est-demande-a-lassurance-maladie-2117573.php
- Le déremboursement des médicaments en France entre 2002 et 2011: éléments d’évaluation. [cited 2011 Jul 01]. Available from: www.irdes.fr/Publications/2011/Qes167.pdf
- NICE and NHS England consultation on changes to the arrangements for evaluating and funding drugs and other health technologies assessed through NICE’s technology appraisal and highly specialised technologies programmes. cited 2017 Mar 15. Available from: https://www.nice.org.uk/Media/Default/About/what-we-do/NICE-guidance/NICE-technology-appraisals/board-paper-TA-HST-consultation-mar-17-HST-only.pdf
- Changes to NICE drug appraisals: what you need to know. [cited 2017 Apr 04]. Available from: https://www.nice.org.uk/news/feature/changes-to-nice-drug-appraisals-what-you-need-to-know
- Pros and cons of the new AIFA innovation algorithm: a critical analysis. [cited 2017 May 04]. Available from: https://www.linkedin.com/pulse/pros-cons-new-aifa-innovation-algorithm-critical-fabrizio-gianfrate/
- Navarria A, Drago V, Gozzo L, et al. Value Health. 2015;18:131–8.
- Aggiornamento: elenchi dei farmaci che accedono ai fondi dei farmaci innovativi istituiti ai sensi della Legge di Bilancio 2017. [cited 2017 Dec 21]. Available from: http://www.aifa.gov.it/content/aggiornamento-elenchi-dei-farmaci-che-accedono-ai-fondi-dei-farmaci-innovativi-istituiti-a-1
- Epatite C: sovaldi e Harvoni non saranno più rimborsati dal Ssn. [cited 2017 Jun 05]. Available from: http://www.sanita24.ilsole24ore.com/art/imprese-e-mercato/2017-06-05/epatite-c-sovaldi-e-harvoni-non-saranno-piu-rimborsati-ssn-ma-gilead-adesso-s-e-epclusa–095450.php?uuid=AEp1tpYB
- Real Decreto-ley 16/2012, de 20 de abril, de medidas urgentes para garantizar la sostenibilidad del Sistema Nacional de Salud y mejorar la calidad y seguridad de sus prestaciones. [cited 2012 Apr 24]. Available at: https://www.boe.es/buscar/pdf/2012/BOE-A-2012-5403-consolidado.pdf
- Sanidad estudia si es legal que Valencia dé en AP fármacos preparados en hospital. [cited 2013 Sept 23]. Available from: http://www.farmaindustria.es/idc/groups/public/documents/noticia/farma_122257.pdf
- Los pacientes de hepatitis C serán tratados con los nuevos medicamentos de acuerdo con los criterios del Plan Estratégico. [cited 2015 Feb 26]. Available from: https://www.msssi.gob.es/gabinete/notasPrensa.do?id=3576
- Ministerio de Sanidad, Servicios Sociales e Igualdad. Pliego de prescripciones técnicas del acuerdo marco para la selección de suministradores de productos sanitarios para varias comunidades autónomas y organismos de la administración general del estado. Madrid. [cited 2017 Feb 12]. https://www.redaccionmedica.com/contenido/images/DOCUMENTO_2%281%29.pdf
- Acuerdo marco suministro de lancetas de punción y tiras reactivas de medición de glucosa en sangre capilar, con destino a las diferentes organizaciones de Osakidetza. Vitoria; [cited 2018 Feb 02]. Available from: https://www.osakidetza.euskadi.eus/r85-ekcont02/es/contenidos/anuncio_contratacion/exposakidetza27858/es_doc/es_arch_exposakidetza27858.html?ruta=/r85-ekcont01/es/v79aWar/comunJSP/v79aSuscribirRSS.do?=R01HPortal=r85&R01HPage=ekcont01&R01HLang=es&widget=true&p01=AL&p02=&p03=40&p04=&p05=&p06=&p07=&p08=&p09=&p10=&p11=&p12=&p13=&p14=&p15=&p16=&p17=AMPLIADO&p18=false&p19=false&p20=false&p21=es&p22=ultimos30dias&p23=&p24=r85-ekcont01&p25=r85-ekcont02
- The Health and Medical Services Act, Ministry of Health and Social Affairs. 1995. Swedish Government proposition 1996/97:60.
- Introduktion till hälsoekonomisk utvärdering. [cited 2017 Feb 12]. Available from: https://www.tlv.se/download/18.467926b615d084471ac3396b/1510316350460/introduktion-halsoekonomi.pdf
- Hepatit C. [cited 2015 Oct 15]. Available from: https://www.tlv.se/download/18.22f5c35f16020eae8d83cfb6/1512565506906/underlag_bes_hepatis_c_dnr1224_2014.pdf
- Kamerbrief over de voortgang Financiële Arrangementen geneesmiddelen 2017. [cited 2017 Sept 25]. Available from: https://www.rijksoverheid.nl/documenten/kamerstukken/2017/09/25/kamerbrief-over-de-voortgang-financiele-arrangementen-geneesmiddelen-2017
- The BeNeLuxA initiative aims to ensure sustainable access to innovative medicine at affordable cost for our patients. [cited 2017 Sept 06]. Available from: www.beneluxa.org
- NASH- the next big global epidemic in 10 years? [cited 2014 Jul 14]. Available from: www.pharmaxis.com.au/assets/Documents/pdf/2015/Other-documents-and-files/Deutsche-Bank-Markets-Research-14-July-2014-NASH-the-next-big-global-epidemic-in-10-years.pdf
- New cystic fibrosis drug ivacaftor (Kalydeco) to be made available for Irish patients. [cited 2013 Feb 01]. Available from: health.gov.ie/blog/press-release/new-cystic-fibrosis-drug-ivacaftor-kalydeco-to-be-made-available-for-irish-patients/
- HSE must fund new high-tech drugs, says department of health. [cited 2017 Jul 27]. Available from: https://www.irishtimes.com/business/energy-and-resources/hse-must-fund-new-high-tech-drugs-says-department-of-health-1.3169032